719 results found.
                    
Bundled Payments: AAOS Conversations Center on CJR and Beyond
By Carolyn LaWell The advent of the Centers for Medicare & Medicaid’s Comprehensive Care for Joint Replacement (CJR) program fueled AAOS Annual Meeting conversations regarding the best response by hospitals, surgeons and device companies to bundled payment re...
Medtronic Launches AVILA Interbody Fusion Devices in the EU
Medtronic commenced EU launch of AVILA™ devices, intended for use in open and minimally invasive anterio...
Life Spine Receives FDA Clearance for PROLIFT Expandable Interbody System
Life Spine received FDA 510(k) clearance to market the PROLIFT® Expandable Interbody System fo...
Company Revenue 2015: K2M
2015: $215.9MM, +16.9% CC (U.S. $155.3MM, +16.7%; ex-U.S. $60.7MM, +17.7% CC) 4Q15: $54.2MM, +10.7% CC ORTHOWORLD estimates 2015 segment revenue and as-reported growth as follows. Spine $211.5MM, +15.6% Orthobiologics $4.4MM, +18.6% ...
Medtronic Posts FY3Q16 Spine Revenue
Medtronic posted FY3Q16 spinal revenue of US $704MM, -2% CC vs. FY3Q15. (U.S. $506MM, -3%; ex-U.S. ~$198MM, -9%
Company Revenue 2015: Medtronic
Calendar year 2015: $2,931.0MM, -2.8% as reported FY3Q16 (period ended 1/29/16): $704MM, -2% CC (U.S. $506MM, -3%; ex-U.S. ~$198MM, -9% as-reported) ORTHOWORLD estimates 2015 segment revenue and as-reported growth as follows.
Emerging Business Models Address Disruption in Orthopaedics
By April C. Bright To offset the shifting economic and regulatory environment, Bill Tribe, Ph.D., partner at consulting firm A.T. Kearney, foresees the need for companies to abandon traditional business models and begin to develop and implement distinctive, proprietary ones. Tho...
FDA Panel Convenes to Discuss Medtronic's DIAM Spinal Stabilization System
On 2/19/16, FDA's Orthopaedic and Rehabilitation Devices Panel will meet regarding the PMA for Medtronic's D...
VEXIM Initiates New Clinical Study of SpineJack vs. Conservative Treatment of VCFs
Vexim initiated a new clinical study in France to compare 1-year and 2-year follow-up of
Vexim Hits Milestone, 25,000 SpineJack Units Sold
Vexim achieved a milestone of 25,000 SpineJack® units sold since market launch in 2011....
FDA Approves Medtronic's INFUSE Bone Graft for New Spine Indications
FDA has approved additional spine surgery indications for Medtronic's Infuse® Bone Graft, s...
Medtronic Reports FY2Q16 Revenue
Medtronic posted FY2Q16 (ended 10/30/15) spinal revenue of
Investors Shy From Start-Up Risk, Continue to Back Growth-Stage Companies
By Carolyn LaWell Investors continue to back growth-stage device companies and those at the intersection of medical and information technology, as opposed to start-ups—a trend that is expected to endure in 2016. The investment community’s oppositio...
Funding Sources: Four Company Snapshots
By Hannah Corcoran Securing funding is a critical step for companies as they jump the hurdles to market entry. The most common way that early-stage companies seek funding is to issue equity to investors (usually preferred stock, sometimes common stock), a...
NASS Revises Coverage Recommendation for Cervical Artificial Disc Replacement
The North American Spine Society (NASS) has revised its formal coverage recommendation for Cervical Artificial Disc Re...
Study Refutes Increased Cancer Risk after rhBMP for Spinal Fusion
Studies investigating use of recombinant human bone morphogenetic protein (rhBMP) in spinal fusion found high rates o...
Greatbatch Announces 3Q15 Revenue, Comments on Acquisition
Greatbatch posted 3Q15 orthopaedic revenue of US $27.5MM, -15% from 3Q14 (-7% in organic constant currency). 
Greatbatch Completes Acquisition, to Rebrand as Integer
Greatbatch, a supplier of implants, instruments, cases and trays to orthopaedic OEMs, completed its acquisition of
NASS 2015: Interbody Fusion, SI Joint, Robotics Take Spotlight
By Carolyn LaWell While the spine market continues to grow in the low-single-digits, small- to mid-sized pure-play companies remain confident that their data-backed products will keep taking market share from larger, diversified players. That sentiment carried...
Spine Spotlight: A Look Back, a Look Ahead
News from NASS reaffirmed industry trends that we cited in this year’s edition of THE O...
Study: Prestige LP Cervical Disc Patients Maintained Improved Clinical Outcomes, Patient Satisfaction vs. Fusion at 7 Years
Seven-year study data indicate that Medtronic's Prestige LP™ cervical disc maintained improved clinical ...
Biologica Technologies Introduces ProteiOS Growth Factor
Biologica Technologies is debuting ProteiOS™, growth factor derived from minimally manipulated allogenei...
NASS Preview: Products and Companies to Watch
By Julie Vetalice Spine-centric product news and personnel announcements are ramping up as we near the mid-October annual meeting of NASS, the North American Spine Society. Recent analyst notes suggest that pure-play companies continue to outperform larger diversifi...
Orthopaedic Investments Not Halted by China’s Challenged Economy
By Carolyn LaWell While China’s stock market volatility has disrupted global markets and fueled fears of a sliding economy, current events haven’t appreciably affected the country’s healthcare market and shouldn’t deter medical device i...
BARE BONES® - September 3, 2015
Medtronic posted FY1Q16 (ended 7/31/15) spinal revenue of US $763MM, +7% from FY1Q15. (Core Spine WW flat, U.S. declined in mid-single digits; Interventional Spine WW declined in mid-single digits, U.S. declined high-single di...
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group